Curis, Inc. (CRIS) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2012
Loading P/E history...
CRIS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Curis, Inc. (CRIS) trades at a price-to-earnings ratio of -1.1x, with a stock price of $0.62 and trailing twelve-month earnings per share of $-0.06.
The current P/E is 100% below its 5-year average of 284.4x. Over the past five years, CRIS's P/E has ranged from a low of 20.9x to a high of 635.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, CRIS trades at a 105% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, CRIS trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CRIS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CRIS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 15.2 | - | +1747%Best | |
| $6B | 8.6 | - | +264% | |
| $2B | 6.8Lowest | 0.66Best | +817% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CRIS Historical P/E Data (2003–2012)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2012 Q3 | Sun Sep 30 2012 00:00:00 GM | $414.00 | $2.10 | 197.1x | -31% |
| FY2012 Q2 | Sat Jun 30 2012 00:00:00 GM | $540.00 | $0.85 | 635.3x | +123% |
| FY2003 Q3 | $439.00 | $21.00 | 20.9x | -93% |
Average P/E for displayed period: 284.4x
See CRIS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRIS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRIS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRIS — Frequently Asked Questions
Quick answers to the most common questions about buying CRIS stock.
Is CRIS stock overvalued or undervalued?
CRIS trades at -1.1x P/E, below its 5-year average of 284.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does CRIS's valuation compare to peers?
Curis, Inc. P/E of -1.1x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is CRIS's PEG ratio?
CRIS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2003-2012.